Home › Companies › Takeda Pharmaceutical Co., Ltd.
How asset managers voted at Takeda Pharmaceutical Co., Ltd.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Takeda Pharmaceutical Co., Ltd. | 49 | 103 |
| 2024-2025 | Takeda Pharmaceutical Co., Ltd. | 29 | 101 |
| 2023-2024 | TAKEDA PHARMACEUTICAL CO. LTD. | 44 | 117 |
Earlier seasons list this company under the name TAKEDA PHARMACEUTICAL CO. LTD., as its holders filed it.
Explore Takeda Pharmaceutical Co., Ltd. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. This page is rebuilt weekly; built November 9, 2026.